loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 203062 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AUROBINDO PHARMA LTD (2)

filter

01 TABLET, ORALLY DISINTEGRATING;ORAL (2)

filter

01 RX (2)

filter

01 RIZATRIPTAN BENZOATE (2)

filter

01 No (2)

URL Supplier Web Content
TABLET, ORALLY DIS...
EQ 5MG BASE
2013-07-01
203062
RIZATRIPTAN BENZOA...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DIS...
EQ 10MG BASE
2013-07-01
203062
RIZATRIPTAN BENZOA...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 203062

Looking for FDA Orange Book APPLICATION 203062 2

19

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is RIZATRIPTAN BENZOATE, with a corresponding application number 203062.

Regulatory Information RX

With a dosage strength EQ 5MG BASE

Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

Reference Listed Drug No

Approved since 2013-07-01

Therapeutic Equivalence (TE) Code AB

18

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is RIZATRIPTAN BENZOATE, with a corresponding application number 203062.

Regulatory Information RX

With a dosage strength EQ 10MG BASE

Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

Reference Listed Drug No

Approved since 2013-07-01

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY